Biberach, Germany

Horst Lechner

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Karl Thomae Gmbh. Active years: 1984.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Horst Lechner: Innovator in Pharmaceutical Formulations

Introduction

Horst Lechner is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of delayed-release medications. His innovative work has led to the development of a unique composition for the administration of bromhexine.

Latest Patents

Horst Lechner holds 1 patent for his invention titled "Bromhexine delayed-release pharmaceutical form." This invention focuses on vehicles for the administration of bromhexine, specifically a composition that allows for the delayed release of the drug. The formulation includes spheroid particles or tablets containing bromhexine and pharmacologically acceptable acids, designed to optimize the drug's effectiveness.

Career Highlights

Lechner is associated with Dr. Karl Thomae GmbH, where he has applied his expertise in pharmaceutical sciences. His work has been instrumental in advancing the delivery methods of important medications, enhancing patient outcomes through innovative formulations.

Collaborations

Throughout his career, Horst Lechner has collaborated with esteemed colleagues such as Peter Gruber and Eckhart Bauer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.

Conclusion

Horst Lechner's contributions to the field of pharmaceuticals, particularly through his patent for bromhexine delayed-release formulations, highlight his role as a key innovator. His work continues to impact the way medications are delivered, improving therapeutic efficacy for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…